Oculis Holding AG OCS
NASDAQ OCS
$12.17 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Oculis Holding AG (OCS) Change in Cash (2022 - 2026)

Oculis Holding AG (OCS) posted quarterly Change in Cash of -$22.0 million for Q1 2026, down 159.36% year-over-year from $37.1 million in Q1 2025, and down 150.45% quarter-over-quarter from $43.7 million in Q4 2025.

Analysis

Oculis Holding AG (OCS) Change in Cash (2022 - 2026) Analysis & Trends

Oculis Holding AG's Change in Cash history runs 5 years deep, the most recent figure standing at -$22.0 million for Q1 2026.

  • In Q1 2026, Change in Cash fell 159.36% year-over-year to -$22.0 million; the TTM figure through Mar 2026 stood at $10.5 million (down 74.29% YoY), while the FY2025 annual figure was $72.0 million, up 674.33% from the prior year.
  • Change in Cash for Q1 2026 stood at -$22.0 million, down from $43.7 million in the prior quarter.
  • The five-year high for Change in Cash was $86.1 million in Q1 2023, with the low at -$57.7 million in Q2 2023.
  • The 5-year median for Change in Cash is -$8.1 million (2024), against an average of $2.8 million.
  • The sharpest annual moves came in 2023 and 2025: Change in Cash slumped 205.76% in 2023, then surged 536.38% in 2025.
  • Oculis Holding AG's Change in Cash stood at -$8.6 million in 2022, then soared by 219.37% to $10.3 million in 2023, then sank by 196.97% to -$10.0 million in 2024, then soared by 536.38% to $43.7 million in 2025, then tumbled by 150.45% to -$22.0 million in 2026.
  • Business Quant data shows OCS's Change in Cash at -$22.0 million in Q1 2026, $43.7 million in Q4 2025, and -$22.2 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 649.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.60 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -185.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 427.25 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -2.94 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.42 Mn
10 Oculis Holding AG 634.75 Mn 345.87 Mn - -4.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.64 Mn
Mar 31, 2026 -22.03 Mn
Dec 31, 2025 43.66 Mn
Sep 30, 2025 -22.16 Mn
Jun 30, 2025 11.04 Mn
Mar 31, 2025 37.11 Mn
Dec 31, 2024 -10.01 Mn
Sep 30, 2024 -8.06 Mn
Jun 30, 2024 21.88 Mn
Mar 31, 2024 -17.26 Mn
Dec 31, 2023 10.32 Mn
Sep 30, 2023 -17.36 Mn
Jun 30, 2023 -57.67 Mn
Mar 31, 2023 86.12 Mn
Dec 31, 2022 -8.64 Mn
Sep 30, 2022 -5.68 Mn